MAPT and Alzheimer disease: These results suggest that Aβ+-plaques and AT8+-tau pathology may induce unique and differential alterations of biological processes, at least in the early stages of AD, although Aβ is believed to be the upstream driver of tau pathology in genetic forms of AD [58].